Page 25 - 2022_03-Haematologica-web

Genome wide association study in Immune TTP
(Unité d’Hémaphérèse, Hôpital la Pitié-Salpétrière, Paris); Seguin Amélie (Service de Réanimation Médicale, Centre Hospitalier de Vendée); Servais Aude (Service de Néphrologie, CHU Necker-Enfants Malades); Stépanian Alain (Laboratoire d’Hématologie, Hôpital Lariboisière, Paris); Vernant Jean-Paul (Service d’Hématologie, Hôpital la Pitié-Salpétrière, Paris); Veyradier Agnès (Service d’Hématologie Biologique, Hôpital Lariboisière, Paris); Vigneau Cécile (Service de Néphrologie,
Hôpital Pontchaillou, Rennes); Wynckel Alain (Service de Néphrologie, Hôpital Maison Blanche, Reims) and Zunic Patricia (Service d’Hématologie, Groupe Hospitalier Sud- Réunion, la Réunion).
Funding
This Study was supported by research funding from Shire/Takeda to MAS.
References
1.Scully, M, Yarranton H, Liesner R, et al. Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clini- cal features. Br J Haematol. 2008; 142(5):819-826.
2Tsai H-M, Raoufi M, Zhou W, et al. ADAMTS13-binding IgG are present in patients with thrombotic thrombocy- topenic purpura. Thromb Haemost. 2006;95(5):886-892.
3. Rieger M, Mannucci PM, Kremer Hovinga JA, et al. ADAMTS13 autoantibodies in patients with thrombotic microan- giopathies and other immunomediated dis- eases. Blood. 2005;106(4):1262-1267.
4. Scully M, Hunt BJ, Benjamin S, et al. Guidelines on the diagnosis and manage- ment of thrombotic thrombocytopenic pur- pura and other thrombotic microan- giopathies. Br J Haematol. 2012;158(3):323- 335.
5Scully M, Brown J, Patel R, McDonald V, Brown CJ, Machin S. Human leukocyte antigen association in idiopathic thrombot- ic thrombocytopenic purpura: evidence for an immunogenetic link. J Thromb Haemost. 2010;8(2):257-262.
6.Coppo P, Busson M, Veyradier A, et al. HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency- related idiopathic thrombotic thrombocy- topenic purpura in Caucasians. J Thromb Haemost. 2010;8(4):856-859.
7. John M-L, Hitzler W, Scharrer I. The role of human leukocyte antigens as predisposing and/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpura. Ann Hematol. 2012;91(4):507-510.
8. Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluoro- genic substrate for ADAMTS13 assay. Br J Haematol. 2005;129(1):93-100.
9. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007; 447(7145):661-678.
10. Illumina. “TOP/BOT” Strand and “A/B” Allele - Technical Note. Illumina SNP Genotyping. 2006.
11.Fairfax BP, Makino S, Radhakrishnan J, et al. Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat Genet. 2012;44(5):502-510.
12. Fairfax BP, Humburg P, Makino S, et al. Innate immune activity conditions the effect of regulatory variants upon mono- cyte gene expression. Science. 2014; 343(6175):1246949.
13. Browning BL, Zhou Y, Browning SR. A one-penny imputed genome from next- generation reference panels. Am J Hum Genet. 2018;103(3):338-348.
14. Golden Helix, Inc., Bozeman, MT www.goldenhelix.com. SNP & Variation
Suite TM (Version 8.8.1). Golden Helix, Inc. 15. Fadista J, Manning AK, Florez JC, Groop L. The (in)famous GWAS P-value threshold revisited and updated for low-frequency variants. Eur J Hum Genet. 2016;24(8):
1202-1205.
16.Pruim RJ, Welch RP, Sanna S, et al.
Genet. 2012;90(4):648-660.
30. Wagner M, Sobczyński M, Bilińska M, et
al. Preliminary study on the role of TMEM39A gene in multiple sclerosis. J Mol Neurosci. 2017;62(2):181-187.
31. D’Cunha MA, Pandit L, Malli C. CD6 gene polymorphism rs17824933 is associated with multiple sclerosis in Indian popula- tion. Ann Indian Acad Neurol. 2016; 19(4):491-494.
32. Guarani V, Paulo J, Zhai B, Huttlin EL, Gygi SP, Harper JW. TIMMDC1/C3orf1 func- tions as a membrane-embedded mitochon- drial complex I assembly factor through association with the MCIA complex. Mol Cell Biol. 2014;34(5):847-861.
33. Ishimoto T, Shimada M, Araya CE, Huskey J, Garin EH, Johnson RJ. Minimal change disease: a CD80 podocytopathy? Semin Nephrol. 2011;31(4):320-325.
34. Kow NY, Mak A. Costimulatory pathways: physiology and potential therapeutic manipulation in systemic lupus erythe- matosus. Clin Dev Immunol. 2013;2013: 245928.
35. Saverino D, Simone R, Bagnasco M, Pesce G. The soluble CTLA-4 receptor and its role in autoimmune diseases: an update. Auto Immun Highlights. 2010;1(2):73-81.
36. Fernandez-Valdivia R, Takeuchi H, Samarghandi A, et al. Regulation of mam- malian Notch signaling and embryonic development by the protein O-glucosyl- transferase Rumi. Development. 2011; 138(10):1925-1934.
37. Servián-Morilla E, Takeuchi H, Lee TV, et al. A POGLUT1 mutation causes a muscu- lar dystrophy with reduced Notch signaling and satellite cell loss. EMBO Mol Med. 2016;8(11):1289-1309.
38. Stenflo J, Stenberg Y, Muranyi A. Calcium- binding EGF-like modules in coagulation proteinases: function of the calcium ion in module interactions. Biochim Biophys Acta. 2000;1477(1-2):51-63.
39. Wouters MA, Rigoutsos I, Chu CK, Feng LL, Sparrow DB, Dunwoodie SL. Evolution of distinct EGF domains with specific func- tions. Protein Sci. 2005;14(4):1091-1103.
40. Li Z, Fischer M, Satkunarajah M, Zhou D, Withers SG, Rini JM. Structural basis of Notch O-glucosylation and O-xylosylation by mammalian protein-O-glucosyltrans- ferase 1 (POGLUT1). Nat Commun. 2017;8(1):185.
41. Basmanav FB, Oprisoreanu A-M, Pasternack SM, et al. Mutations in POG- LUT1, encoding protein O-glucosyltrans- ferase 1, cause autosomal-dominant Dowling-Degos disease. Am J Hum Genet. 2014;94(1):135-143.
42. International Multiple Sclerosis Genetics Consortium (IMSGC). Comprehensive fol- low-up of the first genome-wide associa- tion study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. Hum Mol Genet. 2010;19(5):953-962.
43.Sheng Y, Xu J, Wu Y, et al. Association
17.
18. 19.
LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010;26(18):2336-2337.
Jia X, Han B, Onengut-Gumuscu S, et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One. 2013;8(6):e64683.
Lonsdale, J, Thomas, J, Salvatore, M, et al. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45(6):580-585. Machiela MJ, Chanock SJ. LDlink: a web- based application for exploring population- specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics. 2015;31(21):3555- 3557.
20.Wang J, Zhuang J, Iyer S, et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res. 2012;22(9):1798-1812.
21. Bailey TL, Johnson J, Grant CE, Noble WS. The MEME suite. Nucleic Acids Res. 2015;43(W1):W39-49.
22.Westra H-J, Peters MJ, Esko T, et al. Systematic identification of trans eQTLs as putative drivers of known disease associa- tions. Nat Genet. 2013;45(10):1238-1243.
23. Rosenbloom KR, Sloan CA, Malladi VS, et al. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res. 2013;41(database issue):D56-63.
24. Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Res. 2002;12(6):996-1006.
25. Mancini I, Ricaño-Ponce I, Pappalardo E, et al. Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura. J Thromb Haemost. 2016;14(12):2356-2367.
26. Hassed S, Li S, Mulvihill J, Aston C, Palmer S. Adams-Oliver syndrome review of the literature: Refining the diagnostic pheno- type. Am J Med Genet A. 2017;173(3):790- 800.
27. Caron C, DeGeer J, Fournier P, et al. CdGAP/ARHGAP31, a Cdc42/Rac1 GTPase regulator, is critical for vascular development and VEGF-mediated angio- genesis. Sci Rep. 2016;6:27485.
28. Cai X, Huang W, Liu X, Wang L, Jiang Y. Association of novel polymorphisms in TMEM39A gene with systemic lupus ery- thematosus in a Chinese Han population. BMC Med Genet. 2017;18(1):43.
29.Lessard CJ, Adrianto I, Ice JA, et al. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for sys- temic lupus erythematosus in a large-scale multiracial replication study. Am J Hum
haematologica | 2022; 107(3)
581